Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw
It looks to build a pipeline of 28 biosimilars across global markets in three phases.
Jack of all trades, master of none? Nithin Kamath says generalisation, not specialisation leads to success
Kamath attributes his success to b...
India Inc reacts to Coronavirus scare: Anand Mahindra says ‘life imitates art’, Kiran Shaw calls situation ‘scary’
The death toll from the vi...
Not in favour of lowering income tax of very high earners: Kiran Mazumdar Shaw, Biocon
Govt needs to kick start investment cycle by focussing on infrastructure investment. Extending SEZ or initiating new export incentives would...
Biocon will maintain 30% plus operating margins for biologics biz: Kiran Mazumdar Shaw
Syngene also had a good set of numbers this quarter and for the first nine months. Small molecules business has also delivered fairly well. At a quarterly level, we have seen a 14% year-on-year rise in terms of revenues, 18% in terms of EBITDA, says Kiran Mazumdar Shaw, CMD, Biocon. Excerpts from an interview with ETNOW.
Focus on investment and exports to revive investment, economic cycles: Kiran Mazumdar Shaw
In order to restore confidence among private players, government has to bridge the trust deficit. We need consistency in policy because I do not think we should be flip-flopping and that is what investors want to see in any economic climate.
Budget can be pro-growth and still stick to fiscal discipline, & how!
The Budget should focus on reviving private investment, which has been lying low.
Kiran Mazumdar-Shaw conferred with Australia's highest civilian honour
Australia's High Commissioner to India Harinder Sidhu invested Mazumdar-Shaw as an Honorary Member within the Order of Australia (AM) in the General Division at a ceremony in Bengaluru on Friday. An alumnus of Federation University Australia, Mazumdar-Shaw is the founder of Biocon â€“ one of India's largest bio-pharmaceutical companies.
Budget 2020: Biocon boss wants a 'globally competitive' India; Uday Kotak, Harsh Mariwala remain optimistic
India Inc bosses want India to attract global investors.
Why are value mutual funds underperforming?
Many participants at the ET Wealth Investment Workshop wanted to know when the value funds will regain their lost charm. Nilesh Shetty, co-fund manger of the pioneer value fund, Quantum Long Term Equity Value Fund, responded to their queries in detail.
India Inc condemns JNU violence
Harsh Goenka, Harsh Mariwala, Kiran Mazumdar Shaw, and Anand Mahindra, amongst others, voiced their support on Twitter for the JNU students saying that there was no place for violence on educational premises, no matter what the political leanings of those involved.
India Inc reacts to JNU violence: Anand Mahindra tweets ‘doesn’t matter what your faith is’; Biocon boss calls act ‘unpardonable’
Corporate India responded to the campus violence that took place on Sunday.
Millenials not so brand conscious & they are buying on EMIs: Vijay Sales MD
Vijay Sales MD on new trends that have seen sales improving over last few months, especially in December. Last year, November and December were washouts and now we are seeing a higher double digit growth which we have not seen in the last four years at all. Brands also have been very aggressive on marketing as well as pricing front.
Our portfolio companies directly & indirectly employ 400,000 people: Trifecta's Nilesh Kothari
Pioneering the concept of venture debt in the country, Trifecta Capital has come a long way in the past five years. From its partnerships wi...
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service